Kenya Radiotherapy Market Report 2022 to 2030

Kenya Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Kenya Radiotherapy Market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in Kenya is dominated by a few domestic players such as Accuray, Varian Medical Systems, and Elekta. The radiotherapy market in Kenya is segmented into different types, technology, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Kenya Radiotherapy is increasing on account of the rise in cancer cases in the country.

ID: IN10KEPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Kenya AUTHOR: Dr. Vishwa Modhia

Buy Now

Kenya Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Kenya Radiotherapy Market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30.

Kenya is a lower middle-income, developing country in Eastern Africa bordering the Indian Ocean and Lake Victoria. The Kenyan Network of Cancer Organizations (KENCO) is the national umbrella body for roughly 45 registered cancer civil society organizations spread across Kenya that operate in various aspects of cancer treatment and are committed to a collaborative approach to cancer control. Cancer is Kenya's third leading cause of death, trailing only infectious and cardiovascular diseases.

According to the International Agency for Research on Cancer (IARC) GLOBOCAN report for 2018, 47,887 new cancer cases were expected each year, with 32,987 fatalities. Part of the regulatory framework is the Cancer Prevention and Prevention Act, which created the National Cancer Institute to coordinate and manage cancer control initiatives in the country. Kenya's government spent 4.6% of its GDP on healthcare in 2020.

Kenya Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

Currently, 9 Kenyan hospitals and their associated equipment provide radiation cancer treatment services (2021). 7 additional cancer treatment centres have been proposed, and building is underway. Cancer radiotherapy treatment in Kenya began in the 1970s when the Karolinska Institute gave a Cobalt-60 EBRT treatment unit to KNH as part of a Swedish-Kenyan government collaboration. Cancer is becoming more prevalent among Kenyans. According to the Ministry of Health's 2015-2020 medical tourism report, 97% of Kenyans with locally advanced cancer travel to India for treatment. These aspects could boost Kenya's, Radiotherapy Market.

Market restraints

Kenya only has 0.2 radiation machines for every 1,000 cancer patients. Cancer treatment in Kenya is exceedingly expensive, and many cancer patients are anxious about both their illness and the cost of treatment. Individual variables such as race, religion, gender, and socioeconomic background can all contribute to cancer care disparities. Despite the fact that tertiary public hospitals serve more than 80% of the country's cancer patients, almost all of whom are in Nairobi, patient volumes and a lack of modern cancer machines cause treatment interruption and long waiting times, resulting in distress as well as time and financial toxicity. These factors may deter new entrants into the Kenya Radiotherapy Market.

Competitive Landscape

Key Players

Elekta - Elekta is a Swedish company that provides radiation therapy equipment such as linear accelerators and brachytherapy systems to healthcare facilities around the world, including in Kenya
Varian Medical Systems - Varian is a US-based company that specializes in the development and manufacture of radiation therapy equipment such as linear accelerators and brachytherapy systems
Siemens Healthineers - Siemens is a German company that provides a range of medical equipment, including radiation therapy equipment such as linear accelerators and CT simulators
Accuray - Accuray is a US-based company that provides radiation therapy equipment such as the CyberKnife System, which uses precision radiation to treat cancerous and non-cancerous tumours
IBA Worldwide - IBA is a Belgian company that provides radiation therapy equipment such as proton therapy systems and cyclotrons for the production of medical isotopes
Kenyatta National Hospital
Agha Khan University Hospital
The Nairobi Hospital
Texas Cancer Center

Notable Recent Deals

August 2022: Apollo Hospitals Enterprise of India and Kenya's Balmer Healthcare signed a Memorandum of Understanding (MOU). The MOU, according to the Acting Indian High Commissioner to Kenya, will provide Kenyans with better and more modern technology treatment, improved medical investigations, diagnosis, and treatment of diseases that were previously thought to be incurable.

Healthcare Policies and Reimbursement Scenarios

In Kenya, the regulations and reimbursement of radiotherapy are overseen by the Ministry of Health and the National Hospital Insurance Fund (NHIF). The Ministry of Health is responsible for regulating the use of radiation in Kenya, including the use of radiotherapy. The Kenya Society of Radiation Medicine (KSRM) is the main professional organization for radiation oncologists in Kenya and works closely with the Ministry of Health to develop guidelines and standards of practice for radiotherapy. The NHIF is responsible for administering the national health insurance program in Kenya, which provides coverage for radiotherapy services. In addition, the Kenyan government has established the National Cancer Control Strategy, which aims to improve access to cancer care, including radiotherapy, for all Kenyans.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.